skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Entering an established market as a new player can be daunting. Often it’s difficult to know exactly where you should be targeting your trial, and also what patient group you should be targeting your treatment at. Not only that, but how do you really know your treatment will be a success?


For the first time you can get a complete picture of drug potential and what your current competitors are doing within your chosen market through Datamonitor Healthcare.


This infographic is an example of how you can use this exciting new offering as it takes your through everything you need to know before entering the ulcerative colitis market, one of the two dominant forms of IBD. This will enable you to make a confident entry into this market


What will you learn from this exciting new offering in the market place?


  • The number of investigators and prevalent cases of ulcerative colitis in the 7 major markets


  • A list of competitors including the phase their trials are currently in


  • Potential patient share segmented by drug class





Download now

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: